These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 35029303)
21. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. Lee ARYB; Wong SY; Chai LYA; Lee SC; Lee MX; Muthiah MD; Tay SH; Teo CB; Tan BKJ; Chan YH; Sundar R; Soon YY BMJ; 2022 Mar; 376():e068632. PubMed ID: 35236664 [TBL] [Abstract][Full Text] [Related]
22. Convalescent plasma and remdesivir for protracted COVID-19 in a patient with chronic lymphocytic leukaemia: a case report of late relapse after rapid initial response. Schenker C; Hirzel C; Walti LN; Zeerleder SS; Andres M; Ramette A; Barbani MT; Suter-Riniker F; Holbro A; Tritschler T Br J Haematol; 2022 Feb; 196(3):e27-e29. PubMed ID: 34458995 [No Abstract] [Full Text] [Related]
23. SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia. Mellinghoff SC; Mayer L; Robrecht S; Weskamm LM; Dahlke C; Gruell H; Schlotz M; Vanshylla K; Schloser HA; Thelen M; Fink AM; Fischer K; Klein F; Addo MM; Eichhorst B; Hallek M; Langerbeins P Haematologica; 2022 Oct; 107(10):2480-2484. PubMed ID: 35734927 [No Abstract] [Full Text] [Related]
24. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Herishanu Y; Avivi I; Aharon A; Shefer G; Levi S; Bronstein Y; Morales M; Ziv T; Shorer Arbel Y; Scarfò L; Joffe E; Perry C; Ghia P Blood; 2021 Jun; 137(23):3165-3173. PubMed ID: 33861303 [TBL] [Abstract][Full Text] [Related]
25. Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report. Cuneo A; Rigolin GM; Coscia M; Quaresmini G; Scarfò L; Mauro FR; Motta M; Quaglia FM; Trentin L; Ferrario A; Laurenti L; Reda G; Ferrari A; Pietrasanta D; Sportoletti P; Re F; De Paoli L; Foglietta M; Giordano A; Marchetti M; Farina L; Del Poeta G; Varettoni M; Chiurazzi F; Marasca R; Malerba L; Ibatici A; Tisi MC; Stefoni V; Leone M; Baratè C; Olivieri J; Murru R; Gentile M; Sanna A; Gozzetti A; Gattei V; Gottardi D; Derenzini E; Levato L; Orsucci L; Penna G; Chiarenza A; Foà R Hematol Oncol; 2021 Oct; 39(4):570-574. PubMed ID: 34258787 [No Abstract] [Full Text] [Related]
26. Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia. Komissarov AA; Kislova M; Molodtsov IA; Petrenko AA; Dmitrieva E; Okuneva M; Peshkova IO; Shakirova NT; Potashnikova DM; Tvorogova AV; Ptushkin VV; Efimov GA; Nikitin EA; Vasilieva E Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613860 [TBL] [Abstract][Full Text] [Related]
27. Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study. Haydu JE; Maron JS; Redd RA; Gallagher KME; Fischinger S; Barnes JA; Hochberg EP; Johnson PC; Takvorian RW; Katsis K; Portman D; Ruiters J; Sechio S; Devlin M; Regan C; Blumenthal KG; Banerji A; Judd AD; Scorsune KJ; McGree BM; Sherburne MM; Lynch JM; Weitzman JI; Lei M; Kotton CN; Dighe AS; Maus MV; Alter G; Abramson JS; Soumerai JD Blood Adv; 2022 Mar; 6(6):1671-1683. PubMed ID: 35073571 [TBL] [Abstract][Full Text] [Related]
28. Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL. Benjamini O; Gershon R; Bar-Haim E; Lustig Y; Cohen H; Doolman R; Kedmi M; Ribakovsky E; Kneller A; Hod T; Erez N; Levy I; Rahav G; Avigdor A Eur J Haematol; 2023 Jan; 110(1):99-108. PubMed ID: 36208015 [TBL] [Abstract][Full Text] [Related]
29. COVID-19 and Chronic Lymphocytic Leukemia: Where We Stand Now. Chatzikonstantinou T; Herishanu Y; Montserrat E; Ghia P; Cuneo A; Foà R; Scarfò L Cancer J; 2021 Jul-Aug 01; 27(4):328-333. PubMed ID: 34398560 [TBL] [Abstract][Full Text] [Related]
30. The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study. Al-Janabi A; Ra A; Littlewood Z; Foulkes AC; Hunter HJA; Chinoy H; Moriarty CA; Hyrich KL; Limdi JK; Yiu ZZN; Griffiths CEM; Warren RB Br J Dermatol; 2023 Mar; 188(4):542-551. PubMed ID: 36695406 [TBL] [Abstract][Full Text] [Related]
31. COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis. Ito Y; Honda A; Kurokawa M Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e691-e707. PubMed ID: 35459624 [TBL] [Abstract][Full Text] [Related]